Brophy DF - Search Results

1

Continuous-Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding.

Kim JH, Brophy DF, Shah KB. Kim JH, et al. Among authors: brophy df. Cardiol Clin. 2018 Nov;36(4):519-529. doi: 10.1016/j.ccl.2018.06.006. Cardiol Clin. 2018. PMID: 30297069 Review.

2

Tolerability and Biological Effects of Long-Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices.

Malhotra R, Shah KB, Chawla R, Pedram S, Smallfield MC, Priday AG, DeWilde CT, Brophy DF. Malhotra R, et al. Among authors: brophy df. ASAIO J. 2017 May/Jun;63(3):367-370. doi: 10.1097/MAT.0000000000000491. ASAIO J. 2017. PMID: 27922890

3

Multicenter Evaluation of Octreotide as Secondary Prophylaxis in Patients With Left Ventricular Assist Devices and Gastrointestinal Bleeding.

Shah KB, Gunda S, Emani S, Kanwar MK, Uriel N, Colombo PC, Uber PA, Sears ML, Chuang J, Farrar DJ, Brophy DF, Smallfield GB. Shah KB, et al. Among authors: brophy df. Circ Heart Fail. 2017 Nov;10(11):e004500. doi: 10.1161/CIRCHEARTFAILURE.117.004500. Circ Heart Fail. 2017. PMID: 29141860

4

Differences in coagulation in clotting of vascular access in hemodialysis patients.

Nweke C, Martin E, Gehr T, Brophy D, Carl D. Nweke C, et al. Hemodial Int. 2015 Apr;19(2):323-9. doi: 10.1111/hdi.12241. Epub 2014 Nov 21. Hemodial Int. 2015. PMID: 25413181 Clinical Trial.

5

Recombinant activated factor VII use in critically ill patients: clinical outcomes and thromboembolic events.

Brophy GM, Candeloro CL, Robles JR, Brophy DF. Brophy GM, et al. Among authors: brophy df. Ann Pharmacother. 2013 Apr;47(4):447-54. doi: 10.1345/aph.1R729. Epub 2013 Mar 27. Ann Pharmacother. 2013. PMID: 23535812

6

Prospective, randomized comparison of lansoprazole suspension, and intermittent intravenous famotidine on gastric pH and acid production in critically ill neurosurgical patients.

Brophy GM, Brackbill ML, Bidwell KL, Brophy DF. Brophy GM, et al. Among authors: brophy df. Neurocrit Care. 2010 Oct;13(2):176-81. doi: 10.1007/s12028-010-9397-3. Neurocrit Care. 2010. PMID: 20596795 Clinical Trial.

7

Risk of infection with intravenous iron therapy.

Maynor L, Brophy DF. Maynor L, et al. Among authors: brophy df. Ann Pharmacother. 2007 Sep;41(9):1476-80. doi: 10.1345/aph.1K187. Epub 2007 Jul 31. Ann Pharmacother. 2007. PMID: 17666575 Review.

8

Use of enoxaparin in patients with chronic kidney disease: safety considerations.

Brophy DF, Sica DA. Brophy DF, et al. Drug Saf. 2007;30(11):991-4. doi: 10.2165/00002018-200730110-00001. Drug Saf. 2007. PMID: 17973538 Review. No abstract available.

9

Coated platelets and severe haemophilia A bleeding phenotype: Is there a connection?

Lastrapes KK, Mohammed BM, Mazepa MA, Martin EJ, Barrett JC, Massey GV, Kuhn JG, Nolte ME, Hoffman M, Monroe DM, Brophy DF. Lastrapes KK, et al. Among authors: brophy df. Haemophilia. 2016 Jan;22(1):148-51. doi: 10.1111/hae.12844. Epub 2015 Nov 11. Haemophilia. 2016. PMID: 26561343

10

Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis.

Fowler AA 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, Gupta S; Medical Respiratory Intensive Care Unit Nursing; Fisher BJ, Natarajan R. Fowler AA 3rd, et al. Among authors: brophy df. J Transl Med. 2014 Jan 31;12:32. doi: 10.1186/1479-5876-12-32. J Transl Med. 2014. PMID: 24484547 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page